Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
- Wednesday, September 2, 2020, 7:03
- Finance
- Add a comment
KIRKLAND, Wash., Sept. 2, 2020 /PRNewswire/ — Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Therapeutic Goods Administration (TGA) has approved…
About the Author
adminasapcorp has written 39670 stories on this site.